Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Clinical, laboratory, psychometric, and electroencephalographic investigations

Hepatology

Volumn 28, Issue 5, 1998, Pages 1215-1225

  Nolte, Wilhelm ^a,b   Wiltfang, Jens ^a   Schindler, Christian ^a   Münke, Hans ^a   Unterberg, Knut ^a   Zumhasch, Uta ^a   Figulla, Hans R ^a   Werner, Gerald ^a   Hartmann, Heinz ^a   Ramadori, Giuliano ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA;

ADULT; AGED; ARTICLE; BRAIN DISEASE; BRAIN FUNCTION; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PSYCHOMETRY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMMONIA; ELECTROENCEPHALOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PSYCHOLOGICAL TESTS; TREATMENT OUTCOME;

EID: 17344366697     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280508     Document Type: Article

References (17)

1. Sherlock S, Summerskill WHJ, White LP, Phear EA. Portal-systemic encephalopathy. Neurological complications of liver disease. Lancet 1954;ii:453-457.
2. Conn HO, Bircher J. Hepatic Encephalopathy: Syndromes and Therapies. Bloomington, IL: Medi-Ed Press, 1994.
3. Mousseau DD, Butterworth RF. Current theories on the pathogenesis of hepatic encephalopathy. Proc Soc Exp Biol Med 1994;206:329-344.
4. Nolte W, Ramadori, G. Diagnostik der hepatischen Enzephalopathien. Dtsch Med Wochenschr 1996;121:665-669.
5. Mutchnick MG, Lerner E, Conn HO. Portal-systemic encephalopathy and portacaval anastomosis: a prospective controlled investigation. Gastroenterology 1974;66:1005-1019.
6. Sarfeh IJ, Rypins EB, Conroy RM, Mason GR. Portacaval H-graft: relationships of shunt diameter, portal flow patterns and encephalopathy. Ann Surg 1983;197:422-426.
7. Rikkers LE Portal hemodynamics, intestinal absorption, and postshunt encephalopathy. Surgery 1983;94:126-133.
8. Grace ND, Conn HO, Resnick RH, Groszmann RJ, Atterbury CE, Wright SC, Gusberg RJ, et al. Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: a randomized controlled trial. HEPATOLOGY 1988;8:1475-1481.
9. Franco D, Vons C, Traynor O, De Smadja C. Should portosystemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis? Arch Surg 1988;123:987-991.
10. Lacy AM, Navasa M, Gilabert R, Brú C, Garcia-Pagán JC, GarciaValdecasas JC, Grande L, et al. Long-term effects of distal splenorenal shunt on hepatic hemodynamics and liver function in patients with cirrhosis: importance of reversal of portal blood flow. HEPATOLOGY 1992;15:616-622.
11. Planas R, Gomes-Vieira MC, Cabré E, Armengol M, Quer JC, Boix J, Morillas R, et al. Prognostic factors of hepatic encephalopathy after portacaval anastomosis: a multivariate analysis in 50 patients. Am J Gastroenterol 1992;87:1792-1796.
12. Sarfeh IJ, Rypins EB. Partial versus total portacaval shunt in alcoholic cirrhosis. Ann Surg 1994;219:353-361.
13. Häring R. Portale Hypertension interdisziplinär: Stellenwert der portosys-temischen Shuntoperation. Zentralbl Chir 1995;120:95-102.
14. Otto G. Sind chirurgische Shunts noch indiziert? Chirurg 1995;66:566-573.
15. Paquet K-J, Lazar A, Koussouris P, Hotzel B, Gad HA, Kuhn R, Falk J-F. Mesocaval interposition shunt with small-diameter polytetrafluoroethylene grafts in sclerotherapy failure. Br J Surg 1995;82:199-203.
16. Richter GM, Palmaz JC, Nöldge G, Rössle M, Siegerstetter V, Franke M, Wenz W. Der transjugulare intrahepatische portosystemische Stent-Shunt (TIPSS). Radiologe 1989;29:406-411.
17. Shiffman ML, Jeffers L, Hoofnagle JH, Tralka TS. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the national digestive diseases advisory board. HEPATOLOGY 1995;22:1591-1597.